tiprankstipranks
Scinai Immunotherapeutics (SCNI)
NASDAQ:SCNI

Scinai Immunotherapeutics (SCNI) Ownership - Who Owns Scinai Immunotherapeutics?

283 Followers

Scinai Immunotherapeutics (SCNI) Ownership Overview

0.00%0.04%10.27%89.69%
0.00%
Insiders
10.27% Other Institutional Investors
89.69% Public Companies and
Individual Investors
The ownership structure of Scinai Immunotherapeutics (SCNI) stock is a mix of institutional, retail and individual investors. Approximately 10.31% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 89.69% is owned by Public Companies and Individual Investors.
The ownership structure of Scinai Immunotherapeutics (SCNI) stock is a mix of institutional, retail and individual investors. Approximately 10.31% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 89.69% is owned by Public Companies and Individual Investors.

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,376Institution0.04%605
29Institution<0.01%13

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,376Institution0.04%605

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
29Institution<0.01%13

FAQ

Who Owns Scinai Immunotherapeutics (SCNI)?
According to the latest TipRanks data, approximately 10.27% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 89.69% is held by retail investors.
    What percentage of Scinai Immunotherapeutics (SCNI) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 10.27% of Scinai Immunotherapeutics (SCNI) stock is held by institutional investors.
      What percentage of Scinai Immunotherapeutics (SCNI) stock is held by retail investors?
      According to the latest TipRanks data, approximately 89.69% of Scinai Immunotherapeutics (SCNI) stock is held by retail investors.
        Who owns the most shares of Scinai Immunotherapeutics (SCNI)?
        Fidelity Concord Street Trust owns the most shares of Scinai Immunotherapeutics (SCNI).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis